1291 - 1300 of 8826 Results
Title
Year
-
OPENTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 7
-
OPENTitle: Initiation and propagation of α-synuclein aggregation in the nervous systemJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 19End Page: 19Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00368-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00368-6Citation Count: 245
-
OPENTitle: Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and RecommendationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 175End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13586Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9941935Citation Count: 6
- Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping review2025RESTRICTEDTitle: Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping reviewJournal Name: Pharmacological ReviewsPublisher: Elsevier BVVol: 78Issue #: 1Start Page: 100094End Page: 100094Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmr.2025.100094Citation Count: 0
- Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective2022OPENTitle: Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspectiveJournal Name: Animal Models and Experimental MedicinePublisher: WileyVol: 5Issue #: 1Start Page: 27End Page: 37Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ame2.12209Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ame2.12209Citation Count: 26
-
OPENTitle: Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 12Issue #: 6Start Page: 1494End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2021.0527Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=148118Citation Count: 47
-
OPENTitle: Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseasesJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 117Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jleuko/qiaf154Best OA location URL: https://academic.oup.com/jleukbio/advance-article-pdf/doi/10.1093/jleuko/qiaf154/65038951/qiaf154.pdfCitation Count: 0
- Time for a New Image of Parkinson Disease2020RESTRICTEDTitle: Time for a New Image of Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 11Start Page: 1345End Page: 1345Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.2412Citation Count: 45
-
OPENTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7448947Citation Count: 49
- β-adrenoreceptors and the risk of Parkinson's disease2020RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 73